Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | GBA1 | P04062 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | MANBA | O00462 | 2/20 | 0.47 |
| ▸ | IDUA | P35475 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GUSB | P08236 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | OGA | O60502 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PYGB | P11216 | 2/20 | 0.37 |
| ▸ | PYGL | P06737 | 1/20 | 0.37 |
| ▸ | PYGM | P11217 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconolactone SCHEMBL18465607 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL2466472 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL7148519 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL17068350 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631270 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL24637666 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631261 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631260 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL2464302 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631258 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 934 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102005-A1 | FORMULATION OF WOUND DRESSINGS AND THE USES THEREOF | IONIC PHARMACEUTICALS, LLC (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260117068-A1 | PARTICLE HYDROGEL WITH EXCELLENT MECHANICAL PROPERTIES, AND PREPARATION METHOD AND USE THEREOF | HEFEI UNIVERSITY OF TECHNOLOGY (CN) | 2026-04-30 | — | — | US | claimed |
| EP-4731203-A1 | COMPOSITIONS FOR PROMOTING GROWTH OF LACTOBACILLUS CRISPATUS | Gedea Biotech AB (SE) | 2026-04-29 | — | — | EP | claimed |
| US-20260091157-A1 | INJECTABLE AND TEMPERATURE-RESPONSIVE ENHANCED COMPOSITE DUAL-NETWORK MAGNETIC PARTICLE GEL, AND PREPARATION METHOD AND USE THEREOF | HEFEI UNIVERSITY OF TECHNOLOGY (CN) | 2026-04-02 | — | — | US | claimed |
| US-12568978-B2 | Phosphate-free baking powder | PURATOS NV (BE) | 2026-03-10 | — | — | US | claimed |
| CN-121574414-A | Double-network hydrogel coating with high transparency, antibacterial property and toughness, and preparation method and application thereof | 山东大学 | 2026-02-27 | — | — | CN | claimed |
| US-12501922-B2 | Canola based tofu product and method | MANITOBA CANOLA GROWERS ASSOCIATION INC. (CA) | 2025-12-23 | — | — | US | claimed |
| EP-4634900-A1 | MULTIMODAL MONOMATERIAL PHANTOM, AND USE | Christian-Albrechts-Universität zu Kiel - Körperschaft des öffentlichen Rechts (DE) | 2025-10-22 | — | — | EP | claimed |
| US-20250302060-A1 | ALTERNATIVE DAIRY PRODUCTS CONTAINING FUNCTIONAL LIPIDS, AND MANUFACTURING METHODS | BENSOUDA, Yahya (MA) | 2025-10-02 | — | — | US | claimed |
| EP-4611560-A1 | PLANT PROTEIN-BASED CONFECTIONARY MASS | FrieslandCampina Nederland B.V. (NL) | 2025-09-10 | — | — | EP | claimed |
| US-20220192179-A1 | BIOMIMETIC ICE-INHIBITING MATERIAL AND CRYOPRESERVATION SOLUTION COMPRISING SAME | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-23 | — | — | US | claimed |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMIC OF SCIENCES (CN) | 2022-05-12 | — | — | US | claimed |
| CN-114392391-A | Additive manufactured porous polylactic acid scaffold, and biological activity improvement method and application thereof | 吉林大学 | 2022-04-26 | — | — | CN | claimed |
| US-20220095662-A1 | pH Controlled Composition | GENERAL MILLS, INC. (US) | 2022-03-31 | — | — | US | claimed |
| WO-2022066632-A1 | PH CONTROLLED COMPOSITION | GENERAL MILLS, INC. (US) | 2022-03-31 | — | — | WO | claimed |
| CN-114040969-A | Process for preparing an acidified milk product | 诺维信公司 | 2022-02-11 | — | — | CN | claimed |
| EP-2172473-A1 | Alpha, beta-unsaturated, delta-lactones, process for their preparation and their application as pesticides | Instituto Politécnico de Santarém / Escola Superior Agrária (PT) | 2010-04-07 | — | — | EP | claimed |
| US-20080004339-A1 | Sugar derivatives comprising oxiranes or alpha, beta-unsaturated delta-lactones, process for their preparation and their utilisation as pesticides | Instituto Politecnico De Santarem/Escola Superior Agraria (PT) | 2008-01-03 | — | — | US | claimed |
| US-20060025613-A1 | Sugar derivatives comprising oxiranes or alpha, beta-unsaturated gamma-lactones, process for their preparation and their utilisation as pesticides | Instituto Politecnico De Santarem/Escola Superior Agraria (PT) | 2006-02-02 | — | — | US | claimed |
| EP-1464649-A2 | Sugar derivatives comprising oxiranes or alpha,beta-unsaturated gamma-lactones, process for their preparation and their utilisation as pesticides | Instituto Politécnico de Santarém / Escola Superior Agraria (PT) | 2004-10-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | BCL2L1, BCL2, BCL2L11 | LMNA 84/4885GBA1 3042/4885HIF1A 2148/4885 |
| US-20260091157-A1 | INJECTABLE AND TEMPERATURE-RESPONSIVE ENHANCED COMPOSITE DUAL-NETWORK MAGNETIC PARTICLE GEL, AND PREPARATION METHOD AND USE THEREOF | GYS2, PYGL, AGL | LMNA 381/4885GBA1 3192/4885HIF1A 61/4885 |
| US-12568978-B2 | Phosphate-free baking powder | HAO2, LPO, HAO1 | LMNA 3289/4885GBA1 3175/4885HIF1A 3739/4885 |
| US-20260117068-A1 | PARTICLE HYDROGEL WITH EXCELLENT MECHANICAL PROPERTIES, AND PREPARATION METHOD AND USE THEREOF | PYGL, AGL, GLUL | LMNA 1176/4885GBA1 472/4885HIF1A 21/4885 |
| US-20080004339-A1 | Sugar derivatives comprising oxiranes or alpha, beta-unsaturated delta-lactones, process for their preparation and their utilisation as pesticides | OXER1, CBR1, OXSR1 | LMNA 2243/4885GBA1 652/4885HIF1A 1001/4885 |
| US-20220192179-A1 | BIOMIMETIC ICE-INHIBITING MATERIAL AND CRYOPRESERVATION SOLUTION COMPRISING SAME | IGFBP1, IGFBP2, BCL2L1 | LMNA 480/4885GBA1 3798/4885HIF1A 2644/4885 |
| US-20060025613-A1 | Sugar derivatives comprising oxiranes or alpha, beta-unsaturated gamma-lactones, process for their preparation and their utilisation as pesticides | CBR1, OXER1, CBR3 | LMNA 3265/4885GBA1 784/4885HIF1A 1409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.